blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2296701

EP2296701 - CELL-BASED SYSTEMS FOR PRODUCING INFLUENZA VACCINES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.01.2013
Database last updated on 16.09.2024
Most recent event   Tooltip18.01.2013Application deemed to be withdrawnpublished on 20.02.2013  [2013/08]
Applicant(s)For all designated states
Flugen, Inc.
545 Science Drive
Madison, WI 53711 / US
[2011/12]
Inventor(s)01 / BILSEL, Pamuk
9 Boothbay Circle
Madison, WI 83717 / US
02 / KAWAOKA, Yoshihiro
8722 Airport Drive
Middleton, WI 53562 / US
03 / NEUMANN, Gabriele
234 Randolph Drive, apt. 316
Madison, WI 53717 / US
 [2011/12]
Representative(s)Bentham, Andrew
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2011/12]Bentham, Andrew
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date09763471.109.06.2009
[2011/12]
WO2009US46792
Priority number, dateUS20080060653P11.06.2008         Original published format: US 60653 P
US20090169548P15.04.2009         Original published format: US 169548 P
[2011/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009152181
Date:17.12.2009
Language:EN
[2009/51]
Type: A1 Application with search report 
No.:EP2296701
Date:23.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 17.12.2009 takes the place of the publication of the European patent application.
[2011/12]
Search report(s)International search report - published on:EP17.12.2009
ClassificationIPC:A61K39/145, C12N7/00, C12N5/10
[2011/12]
CPC:
A61K39/145 (EP,US); A61K39/12 (EP,US); A61P31/16 (EP);
C12N7/00 (EP,US); C12N2760/16034 (EP,US); C12N2760/16051 (EP,US);
C12N2760/16134 (EP,US); C12N2760/16151 (EP,US); C12N2760/16234 (EP,US);
C12N2760/16251 (EP,US); C12Y204/99007 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/12]
TitleGerman:ZELLBASIERTE SYSTEME ZUR HERSTELLUNG VON GRIPPEIMPFSTOFFEN[2011/12]
English:CELL-BASED SYSTEMS FOR PRODUCING INFLUENZA VACCINES[2011/12]
French:SYSTÈMES À BASE DE CELLULES POUR PRODUIRE DES VACCINS CONTRE LA GRIPPE[2011/12]
Entry into regional phase10.01.2011National basic fee paid 
10.01.2011Designation fee(s) paid 
10.01.2011Examination fee paid 
Examination procedure10.01.2011Amendment by applicant (claims and/or description)
10.01.2011Examination requested  [2011/12]
14.02.2012Despatch of a communication from the examining division (Time limit: M06)
25.08.2012Application deemed to be withdrawn, date of legal effect  [2013/08]
02.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/08]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.02.2012
Fees paidRenewal fee
22.06.2011Renewal fee patent year 03
14.06.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP1103610  (INTROGENE BV [NL]) [X] 16,17 * claims 1,19,30 *;
 [Y]WO2007110776  (NOVARTIS VACCINES & DIAGNOSTIC [DE], et al) [Y] 1-5,12-15 * page 1, lines 4,5 * * page 8, line 28 - page 9, line 4 * * claims 1,33,34 *;
 [XY]  - ZHANG X ET AL, "Stable expression of human alpha-2,6-sialyltransferase in Chinese hamster ovary cells: functional consequences for human erythropoietin expression and bioactivity", BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS, ELSEVIER SCIENCE PUBLISHERS, NL, (19981127), vol. 1425, no. 3, ISSN 0304-4165, pages 441 - 452, XP004276231 [X] 6-11 * page 441 * * abstract * * page 447, column L, paragraph 2 * [Y] 1-5,12-15

DOI:   http://dx.doi.org/10.1016/S0304-4165(98)00095-6
 [DXY]  - LEE E U ET AL, "ALTERATION OF TERMINAL GLYCOSYLATION SEQUENCES ON N-LINKED OLIGOSACCHARIDES OF CHINESE HAMSTER OVARY CELLS BY EXPRESSION OF BETA GALACTOSIDE ALPHA-2 6-SIALYLTRANSFERASE", JOURNAL OF BIOLOGICAL CHEMISTRY, (1989), vol. 264, no. 23, ISSN 0021-9258, pages 13848 - 13855, XP002915039 [DX] 6-11 * page 13848 * * abstract * * page 13848, column R, paragraph L - page 13849, column L, paragraph 1 * * page 13852; figure 6 * [Y] 1-5,12-15
 [DXY]  - MATROSOVICH M ET AL, "Overexpression of the [alpha]-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors", JOURNAL OF VIROLOGY 200308 US, (200308), vol. 77, no. 15, ISSN 0022-538X, pages 8418 - 8425, XP002551286 [DX] 16,17 * page 8418, column R, paragraph 1 - page 8419, column L, paragraph 1 * * page 8420, column L, paragraph 2 - page 8421, column L, paragraph 1 * * page 8423, paragraph 3 * [Y] 1-5,12-15

DOI:   http://dx.doi.org/10.1128/JVI.77.15.8418-8425.2003
 [DXY]  - HATAKEYAMA S ET AL, "Enhanced expression of an [alpha]2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor", JOURNAL OF CLINICAL MICROBIOLOGY 200508 US, (200508), vol. 43, no. 8, ISSN 0095-1137, pages 4139 - 4146, XP002551287 [DX] 16,17 * page 4139, column L, paragraph 1 - page 4140, column L, paragraph 1 * * page 4141, column L, paragraph 1 - page 4143, column L, paragraph 1 * [Y] 1-5,12-15

DOI:   http://dx.doi.org/10.1128/JCM.43.8.4139-4146.2005
 [A]  - KUMARI KSHAMA ET AL, "Receptor binding specificity of recent human H3N2 influenza viruses", VIROLOGY JOURNAL, BIOMED CENTRAL, LONDON, GB, (20070509), vol. 4, no. 1, ISSN 1743-422X, page 42, XP021025487 [A] * page 1 * * abstract *

DOI:   http://dx.doi.org/10.1186/1743-422X-4-42
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.